There is evidence that it can enhance endothelial LOX-1 expression and promote endothelial dysfunction by inducing inflammation via the LOX-1/ROS/p38/NF-κB-mediated signaling pathway (Ou et al., 2019). Here, NFKB1 is linked to endothelial dysfunction.